Antihyperglycemic effects of newly synthesized 6,7-bis[2-(substitutedphenyl)-4-oxothiazolidin3yl1 quinoxaline 2,3-(1 FH, 4 H)-diones.
Pawar
P Y
PY
Bhise
S B
SB
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000188:drug therapy; D007004:Hypoglycemic Agents / Q000138:chemical synthesis* / Q000493:pharmacokinetics / Q000494:pharmacology*; D008297:Male; D011810:Quinoxalines / Q000138:chemical synthesis* / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013329:Structure-Activity Relationship; D013844:Thiazoles / Q000138:chemical synthesis* / Q000494:pharmacology*
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D011810:Quinoxalines; D013844:Thiazoles